Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 217,065 shares at $0.99 ($216K) on 2024-12-18, disclosed to the SEC on 2024-12-19.
Tax-driven sale ($216k) by President & CEO — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 46,995 | $47K | 22.0% |
| 2 | $0.99 | 85,035 | $84K | 39.0% |
| 3 | $0.99 | 85,035 | $84K | 39.0% |
| Total | $0.99 avg | 217,065 | $216K | 100% |
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |